Parkinson's Disease
November 2019 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Parkinson's Disease abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Parkinson's Disease. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Parkinson's Disease. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Parkinson's Disease every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Approach to Assessment of Parkinson Disease with Emphasis on Genetic Testing.
Authors:Payne K, Walls B, Wojcieszek J
Institution:Department of Neurology, Indiana University School of Medicine, 355 West 16th Street, Suite 4700, Indianapolis, IN 46202, USA. Electronic address: paynekk@iu.edu.
Journal:Med Clin North Am. 2019 Nov;103(6):1055-1075. doi: 10.1016/j.mcna.2019.08.003. Epub 2019 Aug 31.

2:A new therapeutic strategy with istradefylline for postural deformities in Parkinson's disease.
Authors:Fujioka S, Yoshida R, Nose K, Hayashi Y, Mishima T, Fukae J, Kitano K, Kikuchi H, Tsuboi Y
Institution:Department of Neurology, Murakami Karindoh Hospital, Fukuoka, Japan. tsuboi@cis.fukuoka-u.ac.jp.
Journal:Neurol Neurochir Pol. 2019;53(4):291-295. doi: 10.5603/PJNNS.a2019.0036. Epub 2019 Aug 23.

3:ParkProTrain: an individualized, tablet-based physiotherapy training programme aimed at improving quality of life and participation restrictions in PD patients - a study protocol for a quasi-randomized, longitudinal and sequential multi-method study.
Authors:Siegert C, Hauptmann B, Jochems N, Schrader A, Deck R
Institution:Department Rehabilitation Sciences, Institute for Social Medicine and Epidemiology, University of Lubeck, Ratzeburger Allee 160, 23562, Lubeck, Germany. carolin.siegert@uksh.de. Hamburg, Germany. Germany. Germany.
Journal:BMC Neurol. 2019 Jun 25;19(1):143. doi: 10.1186/s12883-019-1355-x.

4:L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: A systematic review and meta-analysis of randomized controlled trials.
Authors:Zhong R, Chen Q, Zhang X, Li M, Lin W
Institution:Department of Neurology. Lin Province, China.
Journal:Medicine (Baltimore). 2019 Jun;98(24):e16082. doi: 10.1097/MD.0000000000016082.

5:Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.
Authors:Zhao Y, Dzamko N
Institution:Brain and Mind Centre, Central Clinical School, University of Sydney, Camperdown, NSW, 2050, Australia.
Journal:Drugs. 2019 Jul;79(10):1037-1051. doi: 10.1007/s40265-019-01139-4.

6:Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.
Authors:Lyons KE, Pahwa R, Hermanowicz N, Davis T, Pagan F, Isaacson S
Institution:a Department of Neurology , University of Kansas Medical Center , Kansas City , KS , USA. KS , USA. , USA. DC , USA. FL , USA.
Journal:Expert Rev Clin Pharmacol. 2019 Jul;12(7):681-691. doi: 10.1080/17512433.2019.1623669. Epub 2019 Jun 13.

7:Drug treatment strategies for depression in Parkinson disease.
Authors:Ryan M, Eatmon CV, Slevin JT
Institution:a Department of Pharmacy Practice and Science , University of Kentucky College of Pharmacy , Lexington , KY , USA. Healthcare System , Lexington , KY , USA. of Kentucky College of Medicine , Lexington , KY , USA.
Journal:Expert Opin Pharmacother. 2019 Aug;20(11):1351-1363. doi: 10.1080/14656566.2019.1612877. Epub 2019 May 23.

8:Treatment of Neurodegenerative Diseases with Bioactive Components of Tripterygium wilfordii.
Authors:Li J, Hao J
Institution:* School of Pharmacy, Key laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, Hebei, P. R. China. Pomona, CA 91766, USA. Health Sciences, Pomona, CA 91766, USA.
Journal:Am J Chin Med. 2019;47(4):769-785. doi: 10.1142/S0192415X1950040X. Epub 2019 May 15.

9:Deep brain stimulation in parkinson disease.
Authors:Bernardo WM, Rubira C, Silvinato A
Institution:Brazilian Medical Association, Rua Sao Carlos do Pinhal, 324 - Bela Vista, Sao Paulo - SP, Brasil. Paulo - SP, Brasil. Paulo - SP, Brasil.
Journal:Rev Assoc Med Bras (1992). 2019 May 2;65(4):541-546. doi: 10.1590/1806-9282.65.4.541.

10:Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.
Authors:Staff NP, Jones DT, Singer W
Institution:Department of Neurology, Mayo Clinic, Rochester, MN. Electronic address: staff.nathan@mayo.edu.
Journal:Mayo Clin Proc. 2019 May;94(5):892-905. doi: 10.1016/j.mayocp.2019.01.001.

11:Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study.
Authors:Iijima M, Orimo S, Terashi H, Suzuki M, Hayashi A, Shimura H, Mitoma H, Kitagawa K, Okuma Y
Institution:a Department of Neurology , Tokyo Women's Medical University , Tokyo , Japan. School of Medicine , Tokyo , Japan. Japan. Japan. Japan.
Journal:Expert Opin Pharmacother. 2019 Aug;20(11):1405-1411. doi: 10.1080/14656566.2019.1614167. Epub 2019 May 28.

12:Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease.
Authors:Fabbri M, Pongmala C, Artusi CA, Romagnolo A, Rizzone MG, Zibetti M, Lopiano L
Institution:Department of Neuroscience "Rita Levi Montalcini", University of Torino, Turin, Italy. Lisbon, Portugal. Italy.
Journal:Acta Neurol Scand. 2019 Aug;140(2):157-161. doi: 10.1111/ane.13110. Epub 2019 May 13.

13:Parkinson's disease: Mechanisms, translational models and management strategies.
Authors:Raza C, Anjum R, Shakeel NUA
Institution:Department of Zoology, Government College University, Lahore 54000, Pakistan. Electronic address: chandraza@gcu.edu.pk.
Journal:Life Sci. 2019 Jun 1;226:77-90. doi: 10.1016/j.lfs.2019.03.057. Epub 2019 Apr 10.

14:Motor fluctuations and psychological distress in Parkinson's disease.
Authors:Fernie BA, Spada MM, Brown RG
Institution:Department of Psychology.
Journal:Health Psychol. 2019 Jun;38(6):518-526. doi: 10.1037/hea0000736. Epub 2019 Apr 11.

15:Rasagiline and safinamide as a dopamine-sparing therapy for Parkinson's disease.
Authors:Avila A, Caballol N, Martin-Baranera M, Gomez-Ruiz I, Balague-Marmana M, Planas-Ballve A, Cardona X
Institution:Department of Neurology, Hospital Sant Joan Despi Moises Broggi and Hospital General de l'Hospitalet, Consorci Sanitari Integral, Barcelona, Spain.; Department of Clinical Epidemiology, Hospital Sant Joan Despi Moises Broggi and Hospital General de l'Hospitalet, Consorci Sanitari Integral, Barcelona, Spain.; Department of Psychiatry, Hospital Sant Joan Despi Moises Broggi and Hospital General de l'Hospitalet, Consorci Sanitari Integral, Barcelona, Spain.
Journal:Acta Neurol Scand. 2019 Jul;140(1):23-31. doi: 10.1111/ane.13096. Epub 2019 Apr 22.

16:Quality of life in Parkinson's disease: A gender-specific perspective.
Authors:Balash Y, Korczyn AD, Migirov AA, Gurevich T
Institution:Movement Disorders Unit, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Journal:Acta Neurol Scand. 2019 Jul;140(1):17-22. doi: 10.1111/ane.13095. Epub 2019 Apr 23.

17:Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Authors:Dinda B, Dinda M, Kulsi G, Chakraborty A, Dinda S
Institution:Department of Chemistry, Tripura University, Suryamaninagar, Agartala, Tripura, 799 022, India. Electronic address: dindabtu@gmail.com. of Medicine, Charlottesvile, 1300 Jefferson Park Ave, VA, 22908, USA. 151742, Republic of Korea. 799 022, India. India.
Journal:Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.

For a FREE PREVIEW of the Medifocus Guidebook on Parkinson's Disease click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Parkinson's Disease click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Parkinson's Disease...
at a Special 20% Discount


Medifocus Guidebook on Parkinson's Disease

Updated: July 5, 2019
218 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Parkinson's Disease is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

PD33521022

Coupon Expires: December 18, 2019



What Our Customers Are Saying...

"I ordered the MediFocus Guidebook on Parkinson's Disease for my father who has had this condition for about 15 years. It was extremely useful to learn about the medications that are used to treat Parkinson's as well as the side-effects. I had read a lot of articles about Parkinson's on the Internet but they were all very general and vague. Your Guidebook provided excellent and comprehensive information from the medical perspective. Thanks for a very useful resource that is much needed today on the Web."
M.L.
Russelsheim, Germany


"I found your Guidebook on Parkinson's to be very informative for me, the patient, and for my husband. I am in the process of changing my medication and the book explained more to me than the doctor attempted to. I am now more aware of what to expect. It also offered valuable advice for the caregiver. Thank you."
M.N.
Palm Spring, California


"The Medifocus Guide to Parkinson's Disease was useful, informative, and allowed me to grasp the current fundamentals of treatment. I have recommended it to two of my ex-patients whom I know will find it readable and helpful to their needs."
G.B.
Research Triangle Park, NC



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2019 Medifocus, Inc. All rights reserved.